IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01
Published October 14, 2026 · Recall initiated: September 23, 2026
Summary
FDA records drug Class II recall D-0016-2027, published October 14, 2026 and initiated September 23, 2026. Recalling firm: J&J INNOVATIVE MEDICINE; Status: Ongoing; Reported quantity: 49 vials; Lot: Lot JNYJ1208; Exp. 10/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of particulate matter.
What to do
Voluntary: Firm initiated · Letter
Get an email if IMAAVY has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- IMAAVY
- Manufacturer
- J&J INNOVATIVE MEDICINE
- Distributor
- OH
- Lot
- Lot JNYJ1208; Exp. 10/30/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-DoseOctober 14, 2026
- FDATIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosageOctober 14, 2026
- FDALidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro PharmaceuticalsOctober 14, 2026
- FDASEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SCOctober 14, 2026
- FDABiospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDCOctober 14, 2026
- FDASEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensedOctober 14, 2026
Questions about this recall
Was IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01 recalled?
Yes. FDA published recall D-0016-2027 on October 14, 2026. Reported hazard: Presence of particulate matter.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: IMAAVY.